ATE209029T1 - Liposomen, die materialien in partikelform enthalten - Google Patents

Liposomen, die materialien in partikelform enthalten

Info

Publication number: ATE209029T1
Authority: AT; Austria
Prior art keywords: liposomes; water insoluble; particulate; mum; materials
Prior art date: 1993-10-07

Application number

AT94928490T

Other languages

English (en)

Inventor

Gregory Gregoriadis

Sophia George Antimisiaris

Ihsan Gursel

Original Assignee

Secr Defence Brit

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-07

Filing date

1994-10-07

Publication date

2001-12-15

1994-10-07 Application filed by Secr Defence Brit filed Critical Secr Defence Brit

2001-12-15 Application granted granted Critical

2001-12-15 Publication of ATE209029T1 publication Critical patent/ATE209029T1/de

Links

239000002502 liposome Substances 0.000 title abstract 5
239000000463 material Substances 0.000 title abstract 2
239000002245 particle Substances 0.000 title 1
239000011236 particulate material Substances 0.000 abstract 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
238000000034 method Methods 0.000 abstract 2
239000003960 organic solvent Substances 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
210000004102 animal cell Anatomy 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000003054 catalyst Substances 0.000 abstract 1
239000003599 detergent Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
238000004108 freeze drying Methods 0.000 abstract 1
230000001900 immune effect Effects 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/906—Drug delivery
- Y10S977/907—Liposome
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/918—Immunological

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Dispersion Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Manufacturing Of Micro-Capsules (AREA)
Detergent Compositions (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT94928490T 1993-10-07 1994-10-07 Liposomen, die materialien in partikelform enthalten ATE209029T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939320668A GB9320668D0 (en)	1993-10-07	1993-10-07	Liposomes containing particulare materials
PCT/GB1994/002191 WO1995009610A1 (en)	1993-10-07	1994-10-07	Liposomes containing particulate materials

Publications (1)

Publication Number	Publication Date
ATE209029T1 true ATE209029T1 (de)	2001-12-15

Family

ID=10743157

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94928490T ATE209029T1 (de)	1993-10-07	1994-10-07	Liposomen, die materialien in partikelform enthalten

Country Status (15)

Country	Link
US (2)	US6322809B1 (de)
EP (1)	EP0722317B1 (de)
JP (1)	JPH09503225A (de)
KR (1)	KR100357804B1 (de)
CN (1)	CN1108789C (de)
AT (1)	ATE209029T1 (de)
AU (1)	AU687893B2 (de)
BR (1)	BR9407769A (de)
DE (1)	DE69429186T2 (de)
DK (1)	DK0722317T3 (de)
ES (1)	ES2164714T3 (de)
GB (2)	GB9320668D0 (de)
NZ (1)	NZ274006A (de)
RU (1)	RU2145212C1 (de)
WO (1)	WO1995009610A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1289938B1 (it) *	1997-02-20	1998-10-19	Angelini Ricerche Spa	Preparazione farmaceutica comprendente liposomi liofilizzati in cui e' incapsulato un principio attivo altamente insolubile in acqua e
ATE535232T1 (de) *	1997-09-18	2011-12-15	Pacira Pharmaceuticals Inc	Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
IL135989A0 (en)	1997-11-14	2001-05-20	Skyepharma Inc	Processes for the production of multivesicular liposomes
ES2325141T3 (es)	1998-07-17	2009-08-26	Pacira Pharmaceuticals, Inc.	Composiciones biodegradables para la liberacion controlada de sustancias encapsuladas.
FR2802422B1 (fr) *	1999-12-21	2002-08-09	Capsulis	Structures mixtes resultant de l'incorporation d'une macromolecule biologique, en particulier d'adn, dans une phase structuree d'amphiphiles et vesicules obtenues a partir de ces structures
AU2869901A (en) *	2000-02-04	2001-08-14	Lipoxen Technologies Limited	Liposomes
RU2191583C1 (ru) *	2001-03-28	2002-10-27	Лескова Галина Федоровна	Способ коррекции геморрагического шока
EP1395243A2 (de) *	2001-05-31	2004-03-10	SkyePharma Inc.	Verkapselung von nanosuspensionen in liposomen und mikrosphärulen
US20040005352A1 (en) *	2002-04-16	2004-01-08	Lopez Gabriel P.	Biologically functionalized porous microspheres
RU2217129C1 (ru) *	2002-10-28	2003-11-27	Государственный научно-исследовательский институт особо чистых биопрепаратов	Способ получения липосомальных препаратов
SE0300795D0 (sv)	2003-03-24	2003-03-24	Isconova Ab	Composition comprising iscom particles and live micro-organisms
WO2005002546A1 (en) *	2003-06-27	2005-01-13	Smithkline Beecham Corporation	Stabilized topotecan liposomal composition and methods
WO2007041627A1 (en) *	2005-10-03	2007-04-12	Pinsky Mark A	Compositions and methods for improved skin care
FR2900576B1 (fr) *	2006-05-03	2008-09-19	Centre Nat Rech Scient	Procede de concentration extemporanee et reversible de liposomes.
CN101605534A (zh) *	2006-10-06	2009-12-16	Scil技术股份有限公司	脊柱髓核植入物
US9456983B1 (en)	2006-12-08	2016-10-04	Advanced Cardiovascular Systems, Inc.	Therapeutic composition with enhanced vessel targeting
US8372427B2 (en) *	2007-03-05	2013-02-12	Abbott Cardiovascular Systems Inc.	Therapeutic composition with enhanced endothelium targeting
US9044385B2 (en) *	2007-05-16	2015-06-02	Abbott Cardiovascular Systems Inc.	Therapeutic compositions for targeted vessel delivery
US20090047318A1 (en)	2007-08-16	2009-02-19	Abbott Cardiovascular Systems Inc.	Nanoparticle-coated medical devices and formulations for treating vascular disease
US8709472B1 (en)	2007-11-13	2014-04-29	Abbott Cardiovascular Systems Inc.	Bioactive agent-loaded heart-targeting nanoparticles
AU2008345068A1 (en) *	2007-12-26	2009-07-09	Mark A. Pinsky	Collagen formulations for improved skin care
WO2010135714A2 (en)	2009-05-22	2010-11-25	The Methodist Hospital Research Institute	Methods for modulating adipocyte expression using microrna compositions
WO2011123525A1 (en) *	2010-04-01	2011-10-06	The Regents Of The University Of California	Forming an artificial cell with controlled membrane composition, asymmetry and contents
RU2567746C2 (ru) *	2010-05-28	2015-11-10	ДИАГОН Кфт.	Способ двухфазного получения липосом и способы их применения при изготовлении диагностических реагентов
CN102240531B (zh) *	2011-03-21	2013-07-10	徐涵	一种植物细胞微球及其应用
EP2682106A1 (de) *	2012-07-03	2014-01-08	Phares Pharmaceutical Research N.V.	Verfahren zum Auflösen biologisch aktiver Verbindungen
CA2943190A1 (en) *	2014-03-25	2015-10-01	The Government Of The United States Of America As Represented By The Secretary Of The Army	Non-toxic adjuvant formulation comprising a monophosphoryl lipid a (mpla)-containing liposome composition and a saponin
RU2589822C2 (ru) *	2014-12-02	2016-07-10	Федеральное государственное бюджетное учреждение науки Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН)	Способ доставки борсодержащих препаратов для бор-нейтронозахватной терапии
JP6316182B2 (ja)	2014-12-19	2018-04-25	富士フイルム株式会社	リポソームの製造方法及びリポソーム製造装置
US20170049701A1 (en) *	2015-08-05	2017-02-23	Steven M. Kushner	Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients
KR101687735B1 (ko) *	2015-09-18	2016-12-19	서울대학교 산학협력단	신규의 동결건조보조제 및 새로운 인지질 용해용 혼합용매를 이용한 리포좀 동결분체의 제조방법
KR102714709B1 (ko)	2015-11-02	2024-10-07	바이오아트라, 인코퍼레이티드	조건부 활성 폴리펩티드
CN105483076B (zh) *	2015-12-23	2019-01-25	中国科学院生物物理研究所	一种脂肪体的制备方法及其应用
EP3541815A4 (de)	2016-11-18	2020-07-15	Pacira Pharmaceuticals, Inc.	Multivesikuläre liposomenformulierung mit zinkmeloxicamkomplex-mikropartikeln und verfahren zur herstellung davon
EP3415140A1 (de) *	2017-06-16	2018-12-19	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Verfahren zur herstellung einer funktionellen synthetischen zelle in form eines gigantischen unilamellaren vesikels
US10849924B2 (en)	2017-09-26	2020-12-01	New York Medical College	Compositions and methods for restoring endothelial glycocalyx
JP7157999B2 (ja) *	2018-05-07	2022-10-21	国立研究開発法人産業技術総合研究所	微生物を封入したベシクルを用いた微生物の培養方法
JP2023543527A (ja)	2020-09-16	2023-10-16	アビセーダセラピューティクス，インコーポレイテッド	シアル酸リガンド修飾治療薬
US11357727B1 (en)	2021-01-22	2022-06-14	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en)	2021-01-22	2024-11-26	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en)	2021-01-22	2021-06-15	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en)	2021-01-22	2022-03-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en)	2021-10-14	2024-08-14	Pacira Pharmaceuticals Inc	Bupivacaine multivesicular liposome formulations and uses thereof
WO2023129737A1 (en)	2021-12-31	2023-07-06	Aviceda Therapeutics, Inc.	Glycomimetic ligands
EP4694933A1 (de)	2023-04-14	2026-02-18	Aviceda Therapeutics, Inc.	Polysialinsäure-polymer-konjugat und nanopartikel
US12280149B1 (en)	2024-05-20	2025-04-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en)	2024-05-20	2025-03-18	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en)	2024-05-20	2024-12-03	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4201767A (en) *	1978-11-08	1980-05-06	Merck & Co., Inc.	Viral liposome particle
HU184141B (en)	1979-12-27	1984-07-30	Human Oltoanyagtermelo	Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof
DE3374837D1 (en) *	1982-02-17	1988-01-21	Ciba Geigy Ag	Lipids in the aqueous phase
US4532089A (en)	1984-01-14	1985-07-30	Northwestern University	Method of preparing giant size liposomes
US4880635B1 (en)	1984-08-08	1996-07-02	Liposome Company	Dehydrated liposomes
EP0172007B1 (de) *	1984-08-10	1991-05-22	Syntex (U.S.A.) Inc.	Stabile Liposome mit wasserlöslichen Arzneimitteln
JPS6150912A (ja)	1984-08-16	1986-03-13	Shionogi & Co Ltd	リポソ−ム製剤の製造法
US4814270A (en)	1984-09-13	1989-03-21	Becton Dickinson And Company	Production of loaded vesicles
JPS6176414A (ja) *	1984-09-21	1986-04-18	Shionogi & Co Ltd	リポソーム製剤の製法
GB8424115D0 (en)	1984-09-24	1984-10-31	Mead Corp	Article tray
US5049390A (en) *	1987-09-02	1991-09-17	Allergy Immuno Technologies, Inc.	Liposome containing immunotherapy agents for treating IgE mediated allergies
US5422120A (en) *	1988-05-30	1995-06-06	Depotech Corporation	Heterovesicular liposomes
US5157207A (en) *	1990-02-06	1992-10-20	Crop Genetics International	Modified plant containing a bacterial insculant
GB9018690D0 (en) *	1990-08-24	1990-10-10	Wellcome Found	Vaccines
DE4136553A1 (de) *	1991-11-06	1993-05-13	Biotechnolog Forschung Gmbh	Impfstoff gegen schleimhauterreger und herstellungsverfahren
ES2114184T3 (es) *	1993-02-12	1998-05-16	Mayo Foundation	Composicion a base de microparticulas en fase condensada y procedimiento.

1993
- 1993-10-07 GB GB939320668A patent/GB9320668D0/en active Pending
1994
- 1994-10-07 EP EP94928490A patent/EP0722317B1/de not_active Expired - Lifetime
- 1994-10-07 NZ NZ274006A patent/NZ274006A/en not_active IP Right Cessation
- 1994-10-07 AU AU77907/94A patent/AU687893B2/en not_active Ceased
- 1994-10-07 GB GB9607359A patent/GB2297907B/en not_active Revoked
- 1994-10-07 DE DE69429186T patent/DE69429186T2/de not_active Expired - Lifetime
- 1994-10-07 CN CN94194325A patent/CN1108789C/zh not_active Expired - Fee Related
- 1994-10-07 AT AT94928490T patent/ATE209029T1/de not_active IP Right Cessation
- 1994-10-07 KR KR1019960701802A patent/KR100357804B1/ko not_active Expired - Fee Related
- 1994-10-07 US US08/624,556 patent/US6322809B1/en not_active Expired - Fee Related
- 1994-10-07 RU RU96110886A patent/RU2145212C1/ru not_active IP Right Cessation
- 1994-10-07 BR BR9407769A patent/BR9407769A/pt not_active Application Discontinuation
- 1994-10-07 WO PCT/GB1994/002191 patent/WO1995009610A1/en not_active Ceased
- 1994-10-07 JP JP7510702A patent/JPH09503225A/ja not_active Ceased
- 1994-10-07 DK DK94928490T patent/DK0722317T3/da active
- 1994-10-07 ES ES94928490T patent/ES2164714T3/es not_active Expired - Lifetime
2001
- 2001-09-27 US US09/963,601 patent/US6451338B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20020041895A1 (en)	2002-04-11
GB9320668D0 (en)	1993-11-24
JPH09503225A (ja)	1997-03-31
WO1995009610A1 (en)	1995-04-13
DK0722317T3 (da)	2002-05-21
EP0722317A1 (de)	1996-07-24
CN1200668A (zh)	1998-12-02
GB2297907B (en)	1997-12-10
KR100357804B1 (ko)	2004-06-14
RU2145212C1 (ru)	2000-02-10
ES2164714T3 (es)	2002-03-01
CN1108789C (zh)	2003-05-21
GB2297907A (en)	1996-08-21
EP0722317B1 (de)	2001-11-21
AU687893B2 (en)	1998-03-05
AU7790794A (en)	1995-05-01
GB9607359D0 (en)	1996-07-03
US6451338B1 (en)	2002-09-17
US6322809B1 (en)	2001-11-27
NZ274006A (en)	1997-02-24
BR9407769A (pt)	1997-03-18
DE69429186D1 (de)	2002-01-03
DE69429186T2 (de)	2002-07-11

Legal Events

Date

Code

Title

Description

2003-02-15

UEP

Publication of translation of european patent specification

Ref document number: 0722317

Country of ref document: EP

2011-07-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE209029T1 (de)	2001-12-15	Liposomen, die materialien in partikelform enthalten
US5044091B1 (en)	1997-12-30	Method of preparing a freeze-dried formulation of a drug
ATE64849T1 (de)	1991-07-15	Formulierung mit langsamer freisetzung.
DE68903442D1 (de)	1992-12-17	Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
ES8707079A1 (es)	1987-07-01	Un metodo para preparar una composicion de accion prolongada, que contiene un agente biologicamente activo
IT1127216B (it)	1986-05-21	Metodo per la preparazione di microemulsioni di sostanze organiche,agente tensioattivo per atture il metodo,e microemulsione ottenuta
HUT47570A (en)	1989-03-28	Insecticides containing as active substance 3-substituated-1-/chlor-tiasole-5-il-methil/-2-nitroamin-1,3-diaza-cycloalkans and process for production of the active substances
HUT50170A (en)	1989-12-28	Fungicides containing as active substance derivatives of acryl acid morpholid and process for production of the active substance
DE68905613D1 (de)	1993-05-06	Pharmazeutische zubereitung.
DE59002154D1 (de)	1993-09-09	Kombinationspraeparate enthaltend rifampicin und thioacetazon sowie gegebenenfalls isonicotinsaeurehydrazid oder ethambutol als aktive wirkstoffe.
ES485842A0 (es)	1981-04-16	Procedimiento para la obtencion de preparados de valepotria-tos en forma de microcapsulas.
CA2173601A1 (en)	1995-04-13	Liposomes containing particulate materials
RU94041037A (ru)	1997-12-10	Способ получения препарата на основе стронция-89
FR2600671B1 (fr)	1991-01-25	Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
Gehring et al.	1992	Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes
HUT44018A (en)	1988-01-28	Insecticides and acaricides containing as active substance 5-amin-1-phenil-pirasole derivatives and process for production of the active substances
RU92015390A (ru)	1995-10-27	Способ извлечения биологически активных веществ из биомассы микроводоросли рода chlorella
JPS579711A (en)	1982-01-19	Preparation of prolonged release type complex
RU17268U1 (ru)	2001-03-27	Ветеринарный препарат
ES484757A1 (es)	1980-05-16	Un procedimiento de preparacion de un agente relajante de los musculos del esqueleto
RU93016862A (ru)	1997-01-10	Водно-глицериновый комплекс (2,3-диоксипропил)-орто-титана-хлорид
SU1649807A1 (ru)	1996-08-20	Способ получения иммобилизованного кардиолипинового антигена для определения специфических антител
DK90184A (da)	1984-09-27	Fremgangsmaade til fremstilling af let resorberbart ''isoxicam''
Borovec	1989	The Bioaccumulation of Metals and Water Re-Treatment Using Bacteria, Fungi and Algae
DE3674238D1 (de)	1990-10-25	Verfahren zur herstellung einer poroesen struktur, die eine in einem bindemittel ausgestreute organische substanz enthaelt.